Covered recipient · General Payments record
JOHN A LOVIER
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2024
$770.22
- Reported across 34 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $261.30 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $109.54 | 4 |
| PFIZER INC. | $40.98 | 2 |
| Agile Therapeutics, Inc. | $32.01 | 2 |
| ABBVIE INC. | $31.52 | 1 |
| Merck Sharp & Dohme Corporation | $29.31 | 1 |
| Sumitomo Pharma America, Inc. | $17.94 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $31.52 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104905410 | CMS |
| Agile Therapeutics, Inc. | $15.10 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154843545 | CMS |
| Agile Therapeutics, Inc. | $16.91 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154844753 | CMS |
| Astellas Pharma US Inc | $18.27 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139275558 | CMS |
| Astellas Pharma US Inc | $31.32 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139293884 | CMS |
| Astellas Pharma US Inc | $31.53 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139374905 | CMS |
| Astellas Pharma US Inc | $28.42 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139409473 | CMS |
| Merck Sharp & Dohme LLC | $29.31 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141673873 | CMS |
| PFIZER INC. | $19.10 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131601500 | CMS |
| PFIZER INC. | $21.88 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131755880 | CMS |
| Sumitomo Pharma America, Inc. | $17.94 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148883650 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.